-
1
المؤلفون: Zhi-Xiang Shen, David Joske, Ramsathish Sivarathinasami, Timothy P. Hughes, Carmen Piccolo, Oleg Zernovak, Luis Meillon, Dawn F. Eng, Ricardo Pasquini, Hagop M. Kantarjian, Jorge E. Cortes, Dong-Wook Kim
المصدر: Blood. 120:3750-3750
مصطلحات موضوعية: medicine.medical_specialty, business.industry, Immunology, Imatinib, Cell Biology, Hematology, Neutropenia, medicine.disease, Biochemistry, Clinical trial, Dasatinib, Regimen, European LeukemiaNet, Nilotinib, Internal medicine, Medicine, business, Adverse effect, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::2cbde6b6a4a352318e3d639bf7965d3aTest
https://doi.org/10.1182/blood.v120.21.3750.3750Test -
2
المؤلفون: Jorge Cortes-Franco, David Joske, Lidia Mongay, Dawn F. Eng, Ricardo Pasquini, Timothy P. Hughes, Luis Meillon, Zhi-Xiang Shen, Jim Wang, Dong-Wook Kim, Hagop M. Kantarjian
المصدر: Blood. 114:4267-4267
مصطلحات موضوعية: Pediatrics, medicine.medical_specialty, Framingham Risk Score, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Biochemistry, Comorbidity, Imatinib mesylate, Interim, medicine, Observational study, Medical history, Disease management (health), business, Sokal Score
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::cf47b7785177e23895f378509bad4ef1Test
https://doi.org/10.1182/blood.v114.22.4267.4267Test